March 2025

Pharma Courses
New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers
11 March 2025

New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder for prior CAR-T therapies to detect and fight.
11 March 2025
UT Health San Antonio develops drug found to more than double survival time for glioblastoma patients

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults.

11 March 2025
Cryo-Electron Microscopy reveals hidden mechanics of DNA Replication, sheds new light on cancer target

Every day, billions of cells in your body divide, helping to replace old and injured cells with new ones. And each time this happens, your entire genetic library your genome, which totals more than 3 billion base pairs of DNA has to be copied, precisely, from the parent cell to the new daughter cell.

11 March 2025
CDSCO approved Durvalumab, cancer treatment of AstraZeneca
AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India to import for sale and distribution of Durvalumab solution for infusion 120 mg/2.4 ml and 500 mg/10 ml (Imfinzi) for an additional indication.
11 March 2025
Sun Pharma to acquire Checkpoint Therapeutics

Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc.  announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company.

10 March 2025
Recruitment for Pharmacists under District Health Committee at Sadar Hospital, 37 vacancies
Diploma in pharmacy from recognized institute. Registered under the Pharmacy Council. Sadar Hospital recruitment
10 March 2025
Opportunity for Pharm.D, M.Pharm, MSc as Clinical Trial Coordinator at MCC-PGIOSR
Pharm.D, MPharm, BDS, MPH, MSc Biostatistics, MSc Clinical Research, MSc Nursing Or MSc Life Science, BTech Biotechnology with Post graduate Diploma in Clinical Research
10 March 2025
Career for Ph.D or M.Pharm, MSc as Research Scientist at JNCASR - Salary Rs. 72,800 month
Dual functional COX-2 inhibiting and antimicrobial NSAID-peptidomimetic conjugates as novel therapy to tackle septic infections. Ph.D, MD, MS, MDS or equivalent degree OR three years of research, teaching, design and development after MVSc, M.Pharm, M.E, M.Tech with at least tree research papers in high impact Journals. Candidates having research experience in organic synthesis, peptide synthesis, purification and characterization will be preferred.
10 March 2025
Job for Pharmacist under the District Integrated Health and Family Welfare Society
Diploma D. Pharm/B. Pharm; Under the National Health Mission, various programs implemented in the district under the District Integrated Health and Family Welfare Society, Nanded have been organized to fill the vacant posts on contractual basis
10 March 2025
Vacancies for M.Pharm, MSc or B.Pharm to work in funded by CSIR-ASPIRE project at Institute of Life Sciences
To carry out nanoparticle formulations and basic cell culture work related to the project. BPharm OR MPharm or equivalent degree with one publication in SCI Journal and should have at least one year research experience are eligible to apply. Candidates with National level examination qualifications such as NET-JRF/NET-LS/GATE or equivalent.